-
公开(公告)号:US20240115153A1
公开(公告)日:2024-04-11
申请号:US18527818
申请日:2023-12-04
Applicant: Medtronic MiniMed, Inc.
Inventor: Andrea Varsavsky , Fei Yu , Michael E. Miller , Ning Yang
IPC: A61B5/0537 , A61B5/00 , A61B5/0538 , A61B5/145 , A61B5/1468 , A61B5/1473 , A61B5/1486 , A61B5/1495 , A61M5/158 , G01N27/02
CPC classification number: A61B5/0537 , A61B5/0538 , A61B5/14532 , A61B5/1468 , A61B5/1473 , A61B5/14865 , A61B5/1495 , A61B5/7221 , A61B5/7246 , A61M5/1582 , G01N27/026 , A61M2005/1726
Abstract: Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
-
公开(公告)号:US11844598B2
公开(公告)日:2023-12-19
申请号:US16391666
申请日:2019-04-23
Applicant: Medtronic MiniMed, Inc.
Inventor: Andrea Varsavsky , Fei Yu , Michael E. Miller , Ning Yang
IPC: A61B5/0537 , A61B5/145 , A61B5/1468 , A61B5/00 , A61M5/158 , A61B5/0538 , A61B5/1473 , A61B5/1495 , A61B5/1486 , G01N27/02 , A61M5/172 , A61M5/142
CPC classification number: A61B5/0537 , A61B5/0538 , A61B5/1468 , A61B5/1473 , A61B5/1495 , A61B5/14532 , A61B5/14865 , A61B5/7221 , A61B5/7246 , A61M5/1582 , G01N27/026 , A61B5/6849 , A61M5/14244 , A61M5/14276 , A61M2005/1726
Abstract: Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
-
公开(公告)号:US20230080129A1
公开(公告)日:2023-03-16
申请号:US17474921
申请日:2021-09-14
Applicant: Medtronic MiniMed, Inc.
Inventor: Ellis Garai , Sarkis D. Aroyan , Anuj M. Patel , Michael E. Miller
IPC: A61B5/145 , G01N27/04 , A61B5/1486
Abstract: A device for determining a glucose level of a patient includes a set of electrodes comprising a first working electrode, a second working electrode, a counter electrode, and a reference electrode. The reference electrode is electrically coupled to the counter electrode. The device further includes a memory and one or more processors implemented in circuitry and in communication with the memory. The one or more processors configured to determine a sensor signal based on current flowing between the first working electrode and the counter electrode and determine an open circuit potential (OCP) signal based on a voltage across the second working electrode and the reference electrode. The one or more processors are further configured to determine the glucose level of the patient based on the sensor signal and the OCP signal and output an indication of the glucose level.
-
14.
公开(公告)号:US11344235B2
公开(公告)日:2022-05-31
申请号:US16117733
申请日:2018-08-30
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Keith Nogueira , Peter Ajemba , Michael E. Miller , Steven C. Jacks , Jeffrey Nishida , Andy Y. Tsai , Andrea Varsavsky
IPC: A61B5/1495 , A61B5/145 , A61B5/1486 , A61B5/00 , G06N5/02 , G16H50/30 , G01N27/02 , G16H20/17 , G16H50/70 , A61B5/1468 , G16H40/40 , A61B5/1455 , A61B5/0205 , A61B5/021 , A61B5/024 , A61B5/11
Abstract: A continuous glucose monitoring system may utilize externally sourced information regarding the physiological state and ambient environment of its user for externally calibrating sensor glucose measurements. Externally sourced factory calibration information may be utilized, where the information is generated by comparing metrics obtained from the data used to generate the sensor's glucose sensing algorithm to similar data obtained from each batch of sensors to be used with the algorithm in the future. The output sensor glucose value of a glucose sensor may also be estimated by analytically optimizing input sensor signals to accurately correct for changes in sensitivity, run-in time, glucose current dips, and other variable sensor wear effects. Correction actors, fusion algorithms, EIS, and advanced ASICs may be used to implement the foregoing, thereby achieving the goal of improved accuracy and reliability without the need for blood-glucose calibration, and providing a calibration-free, or near calibration-free, sensor.
-
15.
公开(公告)号:US20220095965A1
公开(公告)日:2022-03-31
申请号:US17546159
申请日:2021-12-09
Applicant: Medtronic MiniMed, Inc.
Inventor: Jenn-Hann Larry Wang , Michael E. Miller , Raghavendhar Gautham , Yiwen Li , Rajiv Shah
IPC: A61B5/1495 , G01N27/416 , A61B5/00 , A61M5/158 , A61B5/1486 , A61M5/142 , A61B5/1459 , G01R35/00 , A61B5/145 , A61B5/1473 , A61B5/0537 , G01N33/66 , A61M5/172 , G01N27/02 , A61B5/0538 , G01N33/96 , G01N33/49
Abstract: A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.
-
16.
公开(公告)号:US10660555B2
公开(公告)日:2020-05-26
申请号:US16419624
申请日:2019-05-22
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Jenn-Hann Larry Wang , Michael E. Miller , Raghavendhar Gautham , Yiwen Li , Rajiv Shah
IPC: A61B5/1495 , G01N27/416 , A61B5/00 , A61M5/158 , A61B5/1486 , A61M5/142 , A61B5/1459 , G01R35/00 , A61B5/145 , A61B5/1473 , A61B5/053 , G01N33/66 , A61M5/172 , G01N27/02 , G01N33/96 , G01N33/49
Abstract: A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.
-
17.
公开(公告)号:US20190269355A1
公开(公告)日:2019-09-05
申请号:US16419624
申请日:2019-05-22
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Jenn-Hann Larry Wang , Michael E. Miller , Raghavendhar Gautham , Yiwen Li , Rajiv Shah
IPC: A61B5/1495 , A61B5/053 , G01R35/00 , G01N33/66 , G01N27/416 , A61B5/00 , G01N33/96 , G01N33/49 , G01N27/02 , A61M5/172 , A61B5/145 , A61M5/142 , A61B5/1486 , A61M5/158 , A61B5/1459 , A61B5/1473
Abstract: A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.
-
公开(公告)号:US10321844B2
公开(公告)日:2019-06-18
申请号:US14466138
申请日:2014-08-22
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Andrea Varsavsky , Fei Yu , Michael E. Miller , Ning Yang
IPC: A61B5/1495 , A61B5/053 , A61B5/145 , A61B5/1468 , A61B5/00 , A61B5/1473 , A61B5/1486 , G01N27/02 , A61M5/158 , A61M5/172 , A61M5/142
Abstract: Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
-
公开(公告)号:US20190175082A1
公开(公告)日:2019-06-13
申请号:US15840785
申请日:2017-12-13
Applicant: MEDTRONIC MINIMED, INC.
Inventor: ANDREA VARSAVSKY , Michael E. Miller
IPC: A61B5/145 , A61B5/1486 , A61B5/00 , A61B5/1495
Abstract: A pseudo-orthogonally redundant glucose sensor device may include one or more electrochemical peroxide-based glucose sensor(s) and one or more electrochemical oxygen-based sensor(s). The electrochemical peroxide-based glucose sensor(s) may operate as traditional peroxide-based sensor(s), which may include a chemistry stack with glucose oxidase as a catalytic agent. The electrochemical oxygen-based sensor(s) may be used to measure oxygen, as well as to measure glucose by computing differences in oxygen between two working electrodes. In embodiments of the invention, one of the oxygen-based sensors may be used directly as a diagnostic to determine whether each peroxide-based glucose sensor is functioning properly, as well as to determine which modality of sensing to use. Because of the internal oxygen-based reference, the glucose sensor device provides oxygen-resistant glucose sensing, as well as near-orthogonal redundancy.
-
20.
公开(公告)号:US20190076070A1
公开(公告)日:2019-03-14
申请号:US16117733
申请日:2018-08-30
Applicant: MEDTRONIC MINIMED, INC.
Inventor: Keith Nogueira , Peter Ajemba , Michael E. Miller , Steven C. Jacks , Jeffrey Nishida , Andy Y. Tsai , Andrea Varsavsky
IPC: A61B5/145 , A61B5/1495 , A61B5/1486
Abstract: A continuous glucose monitoring system may utilize externally sourced information regarding the physiological state and ambient environment of its user for externally calibrating sensor glucose measurements. Externally sourced factory calibration information may be utilized, where the information is generated by comparing metrics obtained from the data used to generate the sensor's glucose sensing algorithm to similar data obtained from each batch of sensors to be used with the algorithm in the future. The output sensor glucose value of a glucose sensor may also be estimated by analytically optimizing input sensor signals to accurately correct for changes in sensitivity, run-in time, glucose current dips, and other variable sensor wear effects. Correction actors, fusion algorithms, EIS, and advanced ASICs may be used to implement the foregoing, thereby achieving the goal of improved accuracy and reliability without the need for blood-glucose calibration, and providing a calibration-free, or near calibration-free, sensor.
-
-
-
-
-
-
-
-
-